Pan-cancer screening by circulating tumor DNA (ctDNA) – recent breakthroughs and chronic pitfalls-Reference-Cited by-同舟云学术

Pan-cancer screening by circulating tumor DNA (ctDNA) – recent breakthroughs and chronic pitfalls

Published:2022-07-18 Issue:4 Volume:46 Page:247-253
ISSN:2567-9449
Container-title:Journal of Laboratory Medicine
language:en
Short-container-title:

Author:

Holdenrieder Stefan¹,Ungerer Vida¹,Oberhofer Angela¹,Bronkhorst Abel Jacobus¹

Affiliation:

1. Institute for Laboratory Medicine, German Heart Centre , Technical University Munich , Munich , Germany

Abstract

Abstract Early detection is crucial for optimal treatment and prognosis of cancer. New approaches for pan-cancer screening comprise the comprehensive characterization of circulating tumor DNA (ctDNA) in plasma by next generation sequencing and molecular profiling of mutations and methylation patterns, as well as fragmentation analysis. These promise the accurate detection and localization of multiple cancers in early disease stages. However, studies with real screening populations have to show their clinical utility and practicability.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,Discrete Mathematics and Combinatorics

Link

https://www.degruyter.com/document/doi/10.1515/labmed-2022-0029/pdf

Reference45 articles.

1. Bayerische krebsgesellschaft. Available from: http://www.bayerische-krebsgesellschaft.de [Accessed 03 Jul 2022].

2. National Cancer Institute. FDA approved tests and devices. Available from: https://edrn.nci.nih.gov/about/fda-approved-tests [Accessed 03 Jul 2022].

3. Cardoso, LR, Guo, F, Heisser, T, Hackl, M, Ihle, P, De Schutter, H, et al.. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol 2021;22:1002–13. https://doi.org/10.1016/s1470-2045(21)00199-6.

4. Russo, A, Incorvaia, L, Capoluongo, E, Tagliaferri, P, Gori, S, Cortesi, L, et al.. Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies. ESMO Open 2022;7:100459. https://doi.org/10.1016/j.esmoop.2022.100459.

5. Wait, S, Alvarez-Rosete, A, Osama, T, Bancroft, D, Cornelissen, R, Marušić, A, et al.. Implementing lung cancer screening in Europe: taking a systems approach. JTO Clin Res Rep 2022;3:100329. https://doi.org/10.1016/j.jtocrr.2022.100329.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the power of precision medicine: exploring the role of biomarkers in cancer management;Future Journal of Pharmaceutical Sciences;2024-01-05

2. Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular Profiling;Clinical Chemistry;2024-01

3. Transmission of Lung Adenocarcinoma From a Single Donor in 2 Transplant Recipients: A Case Report With Literature Review;Transplantation Proceedings;2023-10

4. Molecular Monitoring in Endometrial Cancer—Ready for Prime Time?;Clinical Cancer Research;2022-11-10

5. New Perspectives on the Importance of Cell-Free DNA Biology;Diagnostics;2022-09-03